Myths busted! SNF therapy is a great place for debunking persistent misconceptions and lore
By
Meg LaPorte
Apr 08, 2018
Despite efforts by the Centers for Medicare & Medicaid Services to clarify Medicare rules via its coverage manuals and local coverage determinations, some rules are just too broad to interpret specifically,...
Lifting the veil
By
John Hall
Apr 04, 2016
Rehab offers promise to many deemed ‘lost’ in the fog, and providers are making strides in better delivering the therapy dementia patients need
Substituting brand-name with generic heart meds yields savings
Dec 09, 2021
Generic substitutions for brand-name medications could save $641 million per year, including $135 million paid by patients
Push for FDA approval of generic insulin continues
By
Haymarket Media
Jan 12, 2007
Experts say the cost of diabetes treatment could drop by 25% if the Food and Drug Administration approved the production and sale of generic insulin, according to a report in the New York Times.
Links between genetic risk, glaucoma prevalence examined
Jul 23, 2021
Polygenic variants tied to similar risk for developing glaucoma as some monogenic variants and are more prevalent in the general population
Generics comprise growing percentage of Part D usage
By
Haymarket Media
Feb 12, 2007
About 60% of all prescription drugs used by beneficiaries in the Medicare Part D program through the third quarter of 2006 were generics, according to the Centers for Medicare & Medicaid Services.
PharMerica achieves 75% generic dispensing rate
Aug 04, 2010
PharMerica Corporation announced that the firm leads the long-term care pharmacy industry in generic medication dispensing, with a rate of over 75%. The company’s generic dispensing rate is on track...
The coronavirus likely began to spread worldwide last year, say researchers
By
Alicia Lasek
May 06, 2020
The pandemic may have started as early as October 2019, quickly adapting to its human host, according to a new genetic analysis.
Seniors should use generics to avoid “doughnut hole,” policymakers say
By
Haymarket Media
Sep 25, 2006
CMS Administrator Mark McClellan is urging greater use of generic drugs by Medicare prescription drug program beneficiaries to cut costs and improve access, he told the Senate Committee on Aging.
Providers still adjusting to new Medicare rules
By
Julie Williamson
Jun 01, 2011
New MDS and RUG-IV rules are revamping how Medicare services are provided and reimbursed. But every indication is that additional changes are coming